$10.910
+0.050 (+0.46%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TDAC Prediction & Forecast by Similar Chart Analysis
Alphio's TDAC stock price prediction model matches the current Translational Development Acquisition Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.92 (+0.11%). The 1-week path is $10.89 (-0.22%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Translational Development Acquisition Corp Stock?
TDAC is a good buy right now due to its recent merger with ProLogium, which has a pre-money valuation of $3.8 billion, indicating significant growth potential. The stock is currently priced at $10.83, which is 77.8% of its 52-week range, suggesting it is near its high. Additionally, the RSI is at 48.77, indicating it is not overbought, which is favorable for entry. However, the main risk is the current ratio of 0.06, indicating potential liquidity issues in the near term.
TDAC stock price ended at $10.91 on Wednesday, after rising +0.46%
Translational Development Acquisition Corp (TDAC) last closed at $10.9099998, gaining +0.46%. These facts feed the 1-day and 1-week TDAC price prediction above.
Forecast Drivers
Translational Development Acquisition Corp (TDAC) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches TDAC, ranked by similarity.
Seasonality analysis for TDAC
Historically the probability of a positive November return for TDAC is 100.00%. March offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TDAC
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $10.26 | $12.46 | $14.16 | +14.22% |
| Dec 2026 | $8.24 | $9.21 | $9.29 | -15.58% |
In 2026, Translational Development Acquisition Corp (TDAC) is projected to range from $8.24 to $14.16.
Translational Development Acquisition Corp 2026 monthly forecast
In Nov 2026, Translational Development Acquisition Corp is projected to average $12.46, with a low of $10.26 and high of $14.16.
In Dec 2026, Translational Development Acquisition Corp is projected to average $9.21, with a low of $8.24 and high of $9.29.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.